IRCT20140820018866N7招募中3 期
Effect of Aromatase inhibitors in combination with oral contraceptive pills versus GnRH agonist on the treatment of uterine myoma
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 45 years（—）
- 性别
- Female
入选标准
- •Presence of at least one uterine myoma with a size of 2 centimeters (cm) or larger in ultrasound
- •aged between 20 and 45 years old
排除标准
- •Receiving other therapeutic strategies for treatment of the myoma
- •Ovarian cyst or neoplasm
- •Size of largest myoma larger than 10 cm
- •More than 5 myomas
- •Endometrial or cervical pathology
- •exposure to hormonal agents in last month before the trial began
- •Hepatic, cardiovascular and Renal diseases, peptic ulcer, malignancy, and other serious medical conditions
- •Pregnancy or lactation
- •Indication or tendency for surgical intervention
研究者
相似试验
已完成
1 期
Comparing the effect of Aromatase inhibitor (Letrozol) + Cabergoline (Dostinex) and letrozol alone on uterine myoma regressioIRCT201506205283N12Vice chancellor for Research,Tabriz University Of Medical Sciences76
招募中
2 期
Comparison of effects of an aromatase inhibitor with human gonadotropin in clomiphene-resistant polycystic ovary syndromeIRCT20211120053119N1Iran University of Medical Sciences120
尚未招募
1 期
Effect of aromatase inhibitor with LH-RH agonisit for tamoxifen resistant recurrent breast cancerRecurrent breast cancerJPRN-UMIN000004365The University of Tokushima graduate school50
招募中
2 期
AFTER trialmetastatic postmenopausal breast cancer with refractory to estrogen therapyJPRN-UMIN000013890Department of Breast and Endocrine Surgery Graduate school of Medical Sciences, Kumamoto University60
已完成
2 期
Study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological cancersHormone responsive recurrent/metastatic gynaecological neoplasmsMalignant neoplasms of female genital organsCancerISRCTN43261139HS Greater Glasgow and Clyde (UK)350